Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohortsGanqiang Liu, Scott McGinnis, Anthony E. Lang et al.|The Lancet Neurology|2017Cited by 189
Penetrance estimate of <i>LRRK2</i> p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryAnnie Lee, Karen Marder, Yuanjia Wang et al.|Movement Disorders|2017Cited by 170
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0
AZP2006 in Progressive Supranuclear Palsy: A Multi-Centre, Randomized, Phase 2a Trial Assessing Safety and Biomarker OutcomesJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|SSRN Electronic Journal|2024Cited by 0
<scp>AZP2006</scp> in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open‐Label Extension on Safety, Biomarkers, and Disease ProgressionJean‐Christophe Corvol, Luc Defebvre, Mickaël Alexandre Obadia et al.|Movement Disorders|2025Cited by 0